The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Cell Therapy Group
Vancouver, Canada
A
1-10 Employees
2008
Key takeaway
The Cell Therapy Group (CTG) specializes in the cell therapy sector, indicating its relevance to CAR-T cell therapy, which is a significant area within regenerative medicine. With extensive experience in the industry, CTG is well-positioned to support companies involved in this innovative treatment approach.
Highlighted product
Core business
Cell Therapy Group
BlueRock Therapeutics
Old Toronto, Canada
A
101-250 Employees
2016
Key takeaway
BlueRock Therapeutics is focused on discovering and developing innovative cell therapies that have the potential to transform disease treatment and enhance patient lives. Their commitment to regenerative medicine and proprietary technology for creating pluripotent stem cells positions them at the forefront of advancing cellular therapies.
Highlighted product
Product
Platform - BlueRock Therapeutics LP
BlueRock pioneers cell and gene therapies through its platform, utilizing proprietary technology and advanced gene editing.
Centre for Commercialization of Regenerative Medicine
Old Toronto, Canada
A
101-250 Employees
2011
Key takeaway
CCRM focuses on the development and commercialization of cell and gene therapies, including CAR-T cell therapy. With a specialized team and a commitment to addressing process challenges, CCRM supports the entire journey from lab to GMP-compliant manufacturing, facilitating the advancement of innovative regenerative medicine technologies.
Highlighted product
Core business
CCRM | Commercializing Living Therapies
CCRM brings together stakeholders, expertise, infrastructure and funding to accelerate the development and commercialization of regenerative medicines.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Notch Therapeutics
Old Toronto, Canada
A
1-10 Employees
2018
Key takeaway
Notch Therapeutics is focused on maximizing the benefits of cellular immunotherapies, particularly in cancer treatment, where CAR-T cell therapy can provide significant advantages over traditional care methods. The company designs and manufactures therapeutic T cells from pluripotent stem cells, highlighting its commitment to advancing innovative cancer therapies.
Highlighted product
Core business
Notch Therapeutics - Notch Therapeutics
Notch Therapeutics designs and manufactures therapeutic T cells from pluripotent stem cells
STEMSOFT Software
Vancouver, Canada
A
11-50 Employees
1993
Key takeaway
STEMSOFT is dedicated to developing software that enhances the manufacturing and application of cell-based therapies, including CAR-T cell therapy. Their solutions provide configurable electronic batch process records that ensure compliance with industry standards, supporting effective workflows for CAR-T therapy providers.
Highlighted product
Product
Software Solutions for IEC and CAR-T Cell Therapy Providers | STEMSOFT Software
Configurable FACT/JACIE/AABB compliant electronic batch process record for standard of care and advanced medicinal products.
Kymeris Therapeutics
Old Toronto, Canada
A
1-10 Employees
2016
Key takeaway
Kymeris Therapeutics focuses on advancing innovative immunotherapeutic platforms that target solid tumors by reprogramming the tumor microenvironment to enhance immune response. Their expertise in immunology and oncology, supported by a team of dedicated scientists, positions them for effective clinical development of their breakthrough cancer therapies.
Highlighted product
Core business
Home - Kymeris Therapeutics
Kymeris’ Breakthrough Platform Against Solid Cancers – Infiltrates and Reprograms the Tumor Microenvironment –– Turns Cold tumors, Hot –– Delivers Complex Molecular Therapies Inside Tumor – UNIQUE immunoTHERAPEUTIC Eukaryotic PLATFORM Delivering multiple THERAPIES INTO TUMOR Reprograms the Tumor Micro-environment (TME) to reverse cancer-induced local Immunosuppression In extensive preclinical in vivo animal studies, engineered eukaryotic cells have … Home Read More »
Allarta Life Science Inc.
Hamilton, Canada
A
11-50 Employees
2018
Key takeaway
Allarta is a regenerative medicine company focused on advancing cell-based therapies and biologics, with a platform technology for allogeneic cell therapies.
Highlighted product
Core business
Home - Allarta Life Science
Zymeworks
Vancouver, Canada
A
101-250 Employees
2004
Key takeaway
Zymeworks is focused on developing innovative therapies for difficult-to-treat cancers, including their specialized T Cell Engagers. Their proprietary Azymetric™ technology enhances the engineering of bispecific T Cell Engagers, which are crucial for advancing CAR-T cell therapy approaches.
Highlighted product
Product
T Cell Engagers — Zymeworks
Utilizing Azymetric™ to build differentiated and next generation T Cell Engagers
ExCellThera
Montreal, Canada
A
1-10 Employees
2015
Key takeaway
ExCellThera is a clinical-stage company focused on cell expansion and engineering, which is crucial for the development of innovative therapies like CAR-T cell treatments for hematological malignancies. Their expertise in modifying cell lines positions them as a key player in advancing curative therapies for patients with serious diseases.
Highlighted product
Core business
About | ExCellThera
TelCyte Infrastructure
Dartmouth, Canada
A
11-50 Employees
2017
Key takeaway
The company, TelCyte, is a full-service telecom and infrastructure solutions provider, emphasizing the importance of structured processes for operational success.
Highlighted product
Core business
HOME | Telcyte
Technologies which have been searched by others and may be interesting for you:
When exploring the CAR-T Cell Therapy industry in Canada, several key considerations emerge. Regulatory frameworks play a crucial role in the development and commercialization of CAR-T therapies. Health Canada oversees the approval process, ensuring that treatments meet stringent safety and efficacy standards. Understanding these regulations is essential for companies to navigate the approval landscape successfully. The competitive landscape in Canada includes both established pharmaceutical companies and innovative biotech startups, making it vital for new entrants to identify their unique value propositions. Moreover, the industry faces challenges such as high production costs and complex manufacturing processes, which can impact scalability and accessibility of therapies. Opportunities exist due to increasing investments in research and development, driven by the rising prevalence of hematologic malignancies and the growing demand for personalized medicine. Companies should also consider collaborations with academic institutions and research organizations to foster innovation. Additionally, environmental concerns related to waste management in the manufacturing process are becoming increasingly relevant, prompting companies to adopt sustainable practices. Finally, the global market relevance of CAR-T therapies cannot be overlooked, as advancements in this field are taking place worldwide. Monitoring international trends and developments can offer insights into potential partnerships or market expansions for Canadian companies. Overall, thorough research and strategic planning are essential for success in this dynamic industry.
Some interesting numbers and facts about your company results for CAR-T Cell Therapy
| Country with most fitting companies | Canada |
| Amount of fitting manufacturers | 232 |
| Amount of suitable service providers | 175 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1993 |
| Youngest suiting company | 2018 |
Some interesting questions that has been asked about the results you have just received for CAR-T Cell Therapy
What are related technologies to CAR-T Cell Therapy?
Based on our calculations related technologies to CAR-T Cell Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on CAR-T Cell Therapy?
The most represented industries which are working in CAR-T Cell Therapy are Biotechnology, Other, IT, Software and Services, Healthcare, Medical
How does ensun find these CAR-T Cell Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
